| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5ad8562c578b061df7a2c3aee9d0e24 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-48 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-079 |
| filingDate |
2010-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9d07b28bd3ed73f4f077cc1e53dff17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7a3557263ab46d614e4bfe3aba934ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f68c4adbd2c768da2840ff315269771
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79e713d097e36918efdd34d2caeebe95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e50ff699ecf899691615080fb9ebaa0c |
| publicationDate |
2011-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20110125424-A |
| titleOfInvention |
Pain-relieving substances that promote the activity of lyanodine receptors and methods of screening thereof |
| abstract |
TECHNICAL FIELD The present invention relates to the field of neurobiology, and more particularly based on the study of the effect of the activity of the Lyanodine Receptor (RyR) on the signaling of pain in the regulation of intracellular calcium channels. The present invention relates to a pain relief substance and a method for screening the pain relief substance. The pain relief material screening method of the present invention uses the same to screen pain relief materials that can replace conventional painkillers or narcotic painkillers that do not work effectively, thereby blocking pain signals at the thalamus level and thus reducing the risk of addiction. It may be useful for the development of painkillers that can effectively alleviate pain. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102628049-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102628049-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023113429-A1 |
| priorityDate |
2010-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |